Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-Xa Assay Correlation to the Efficacy and Safety of Enoxaparin in the Treatment of Pulmonary Embolism

NCT02977013 is registered in ClinicalTrials.gov with Mohamed Sayed Mohamed Abbas as lead sponsor.

NCT NCT02977013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02977013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-Xa Assay Correlation to the Efficacy and Safety of Enoxaparin in the Treatment of Pulmonary Embolism
Lead sponsor
Mohamed Sayed Mohamed Abbas
Phase
Observational
Overall status
Completed
Start date
August 31, 2013
Completion date
September 30, 2016
Enrollment
42 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anti-xa assay in pulmonary embolism